Biohit Oyj - Managers' Transactions, April 10, 2017 at 12:30 pm local time (EEST)
Biohit Oyj has received the following notification.
Person subject to the notification requirement |
Name: |
Euroclone Spa |
Legal Person |
Position: |
Closely associated person |
|
Person discharging managerial responsibilities in issuer |
Name: |
Aiolfi, Franco |
Position: |
Member of the Board/Deputy member |
|
|
|
|
Initial Notification |
|
Reference number: |
74370089ATTSNBXJVT29_20170410113223_12 |
|
|
|
Issuer |
Name: |
Biohit Oyj |
LEI: |
74370089ATTSNBXJVT29 |
|
|
|
Transaction details |
Transaction date: |
2017-04-05 |
Venue: |
NASDAQ HELSINKI LTD (XHEL) |
Nature of the transaction: |
Disposal |
|
Instrument: |
Share |
ISIN: |
FI0009005482 |
|
Volume: |
35 |
Unit price: |
5,67000 Euro |
Volume: |
79 |
Unit price: |
5,50000 Euro |
Volume: |
75 |
Unit price: |
5,51000 Euro |
Volume: |
406 |
Unit price: |
5,50000 Euro |
Volume: |
379 |
Unit price: |
5,50000 Euro |
Volume: |
905 |
Unit price: |
5,52000 Euro |
Volume: |
553 |
Unit price: |
5,53000 Euro |
Volume: |
2148 |
Unit price: |
5,50000 Euro |
Volume: |
742 |
Unit price: |
5,50000 Euro |
Volume: |
270 |
Unit price: |
5,50000 Euro |
Volume: |
28 |
Unit price: |
5,50000 Euro |
Volume: |
300 |
Unit price: |
5,50000 Euro |
|
Aggregated transactions |
Volume: |
5920 |
Volume weighted average price: |
5.50699 Euro |
Additional information:
CEO Semi Korpela, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com
Biohit in brief
Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com